Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, investing in bold founders, innovators, and entrepreneurs building the future through technology.

a16z is a venture capital firm with $45B in committed capital, founded by Marc Andreessen and Ben Horowitz. A16z invests in technology startups and entrepreneurs across multiple stages and various industries.

Explore Andreessen Horowitz's list of active investment portfolio companies and a list of successful exits filtered by sector or growth stage.

Jan 7, 2022 · Andreessen Horowitz just raised $9B to invest via our Venture, Growth, and Bio funds. Why invest $9B in a brand new set of technology companies?

Marc Andreessen is a cofounder and general partner at the venture capital firm Andreessen Horowitz. He is an innovator and creator, one of the few to pioneer a software category used by more than a billion people and one of the few to establish multiple billion-dollar companies.

May 1, 2019 · That’s why for us, growth is about late-stage venture — aimed at great new companies that are just hitting escape velocity, and that may need a more venture-like mindset to support their further company building and scaling.

Jul 21, 2014 · Marc Andreessen describes his firm’s approach as being similar to Benchmark Capital and Arthur Rock (i.e., focus on big breakthrough ideas), which is unlike other venture firms that have a process where they try to create value-chain maps of where markets/the industry is …

Apr 16, 2024 · Along the way, each submarket – American Dynamism, Apps (Consumer, Enterprise, Fintech), Bio+Health, Crypto, Games, Growth, and Infrastructure – has become as big as the original entire Venture Capital market.

The a16z Growth team supports our portfolio companies across the entire spectrum of company-building including: executive, board, technical, and college talent; go-to-market, pricing, revenue operations; brand and marketing; capital markets and M&A; benchmarking and data analytics; and access to cultural leaders.

Andreessen Horowitz (a16z) Bio + Health today announced a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health, in partnership with Eli Lilly and Company (“Lilly”).